MICHAEL A PACE

Allopathic & Osteopathic Physicians|Internal Medicine LINCOLN, NE NPI 1356352256

General Payments — all program years on this page

$1,831.41

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $375.25 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $375.2513

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $124.721
Mylan Specialty L.P. $68.393
EISAI INC. $48.371
PFIZER INC. $46.113
Novo Nordisk AS $22.991
ABBVIE INC. $19.001
IDORSIA PHARMACEUTICALS US INC $16.891
Amgen Inc. $15.501
Lilly USA, LLC $13.281

By program year

Program yearAmountRecords
2018 $106.332
2019 $426.6010
2020 $291.089
2021 $276.7611
2022 $234.639
2023 $120.766
2024 $375.2513

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097756788 Novo Nordisk Inc $22.99 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105166882 ABBVIE INC. $19.00 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110766181 Eisai Inc. $48.37 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115987028 Amgen Inc. $15.50 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117976484 Boehringer Ingelheim Pharmaceuticals, Inc. $124.72 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131464405 PFIZER INC. $17.25 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131508531 PFIZER INC. $14.23 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132073182 PFIZER INC. $14.63 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135192157 Lilly USA, LLC $13.28 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146768512 IDORSIA PHARMACEUTICALS US INC $16.89 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147306816 Mylan Specialty L.P. $20.59 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147316044 Mylan Specialty L.P. $23.83 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147340503 Mylan Specialty L.P. $23.97 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.